Cutaneous and Systemic Findings in Mosaic Neurofibromatosis Type 1

Pediatric Dermatology

Volumn 34, Issue 3, 2017, Pages 271-276

  Vázquez Osorio, Igor ^a   Duat Rodríguez, Anna ^b   García Martínez, Francisco Javier ^b   Torrelo, Antonio ^b   Noguera Morel, Lucero ^b   Hernández Martín, Angela ^b  

^a HOSPITAL DE CABUEÑES   (Spain)

^b HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROFIBROMIN;

ARTICLE; BASAL CELL CARCINOMA; BONE MALFORMATION; CAFE AU LAIT SPOT; CHILD; CHILDHOOD CANCER; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; EPILEPSY; FEMALE; HODGKIN DISEASE; HUMAN; HYPERPIGMENTATION; LENTIGO; MALE; MOSAIC NEUROFIBROMATOSIS TYPE 1; MOSAICISM; NATIONAL HEALTH ORGANIZATION; NEUROBLASTOMA; NEUROFIBROMA; NEUROFIBROMATOSIS TYPE 1; OPTIC NERVE GLIOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SCOLIOSIS; SKIN DISEASE; SPAIN; SPEECH DISORDER; SYSTEMIC DISEASE; XERODERMA PIGMENTOSUM; ADOLESCENT; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; NEUROFIBROMATOSIS 1; RETROSPECTIVE STUDIES; SKIN DISEASES; SPAIN;

EID: 85017386508     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/pde.13094     Document Type: Article

References (27)

1. Ingordo V, D'Andria G, Mendicini S et al. Segmental neurofibromatosis: is it uncommon or underdiagnosed? Arch Dermatol 1995;131:959–960.
2. Ruggieri M, Huson SM. The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 2001;56:1433–1443.
3. Nunley KS, Gao F, Albers AC et al. Predictive value of cafe au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1. Arch Dermatol 2009;145:883–887.
4. Valero MC, Martin Y, Hernandez-Imaz E et al. A highly sensitive genetic protocol to detect NF1 mutations. J Mol Diagn 2011;13:113–122.
5. Riccardi VM. Neurofibromatosis: clinical heterogeneity. Curr Probl Cancer 1982;7:1–34.
6. Roth RR, Martines R, James WD. Segmental neurofibromatosis. Arch Dermatol 1987;123:917–920.
7. Listernick R, Mancini AJ, Charrow J. Segmental neurofibromatosis in childhood. Am J Med Genet A 2003;121a:132–135.
8. Tanito K, Ota A, Kamide R et al. Clinical features of 58 Japanese patients with mosaic neurofibromatosis 1. J Dermatol 2014;41:724–728.
9. Ruggieri M, Pavone P, Polizzi A et al. Ophthalmological manifestations in segmental neurofibromatosis type 1. Br J Ophthalmol 2004;88:1429–1433.
10. Dang JD, Cohen PR. Segmental neurofibromatosis of the distal arm in a man who developed Hodgkin lymphoma. Int J Dermatol 2009;48:1105–1109.
11. Gonzalez G, Russi ME, Lodeiros A. Bilateral segmental neurofibromatosis: a case report and review. Pediatr Neurol 2007;36:51–53.
12. Lee SH, Roh MR, Kim SC. Multiple segmental neurofibromatosis. J Dermatol 2012;39:810–811.
13. Happle R. Mosaicism in human skin. Understanding the patterns and mechanisms. Arch Dermatol 1993;129:1460–1470.
14. Marque M, Roubertie A, Jaussent A et al. Nevus anemicus in neurofibromatosis type 1: a potential new diagnostic criterion. J Am Acad Dermatol 2013;69:768–775.
15. Tadini G, Brena M, Pezzani L et al. Anemic nevus in neurofibromatosis type 1. Dermatology 2013;226:115–118.
16. Fenot M, Stalder JF, Barbarot S. Juvenile xanthogranulomas are highly prevalent but transient in young children with neurofibromatosis type 1. J Am Acad Dermatol 2014;71:389–390.
17. Hernandez-Martín A, García-Martínez FJ, Duat A et al. Nevus anemicus: distinctive cutaneous finding in NF1. Pediatr Dermatol 2015;32:342–347.
18. Ostendorf AP, Gutmann DH, Weisenberg JL. Epilepsy in individuals with neurofibromatosis type 1. Epilepsia 2013;54:1810–1814.
19. Berg AT, Berkovic SF, Brodie MJ et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia 2010;51:676–685.
20. Schwarz J, Belzberg AJ. Malignant peripheral nerve sheath tumors in the setting of segmental neurofibromatosis. Case report. J Neurosurg 2000;92:342–346.
21. Dang JD, Cohen PR. Segmental neurofibromatosis and malignancy. Skinmed 2010;8:156–159.
22. Ito F, Watanabe Y, Ito T. Synchronous occurrence of Wilms tumor and ganglioneuroblastoma in a child with neurofibromatosis. Eur J Pediatr Surg 1997;7:308–310.
23. Geraci AP, de Csepel J, Shlasko E et al. Ganglioneuroblastoma and ganglioneuroma in association with neurofibromatosis type I: report of three cases. J Child Neurol 1998;13:356–358.
24. Tinschert S, Naumann I, Stegmann E et al. Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene. Eur J Hum Genet 2000;8:455–459.
25. Consoli C, Moss C, Green S et al. Gonosomal mosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1. J Invest Dermatol 2005;125:463–466.
26. Garcia-Romero MT, Parkin P, Lara-Corrales I. Mosaic neurofibromatosis type 1: a systematic review. Pediatr Dermatol 2016;33:9–17.
27. Jobling RK, Lara-Corrales I, Hsiao MC et al. Mosaicism for a SPRED1 deletion revealed in a patient with clinically suspected mosaic NF. Br J Dermatol 2017. doi:10.1111/bjd.14873.